User menu

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Bibliographic reference Batten, Marcel ; Li, Ji ; Yi, Sothy ; Kljavin, Noelyn M ; Danilenko, Dimitry M ; et. al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.. In: Nature Immunology, Vol. 7, no. 9, p. 929-936 (2006)
Permanent URL http://hdl.handle.net/2078.1/123921
  1. Pflanz S., Immunity, 16, 779 (2002)
  2. Hibbert L., J. Interferon Cytokine Res., 23, 513 (2003)
  3. Lucas S., Proc. Natl. Acad. Sci. USA, 100, 15047 (2003)
  4. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T. W., Yoshimura A., Yoshida H., Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment, 10.4049/jimmunol.170.10.4886
  5. Chen Q., Nature, 407, 916 (2000)
  6. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J. F., Phillips J. H., McClanahan T. K., de Waal Malefyt R., Kastelein R. A., WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27, 10.4049/jimmunol.172.4.2225
  7. Sprecher C.A., Biochem. Biophys. Res. Commun., 246, 82 (1998)
  8. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., Saris C., Ehlers S., The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis, 10.4049/jimmunol.174.6.3534
  9. Pearl J. E., Khader S. A., Solache A., Gilmartin L., Ghilardi N., deSauvage F., Cooper A. M., IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice, 10.4049/jimmunol.173.12.7490
  10. Villarino A., Immunity, 19, 645 (2003)
  11. Yoshida H., Immunity, 15, 569 (2001)
  12. Artis D., Villarino A., Silverman M., He W., Thornton E. M., Mu S., Summer S., Covey T. M., Huang E., Yoshida H., Koretzky G., Goldschmidt M., Wu G. D., de Sauvage F., Miller H. R. P., Saris C. J. M., Scott P., Hunter C. A., The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity, 10.4049/jimmunol.173.9.5626
  13. Hamano S., Immunity, 19, 657 (2003)
  14. Miyazaki Y., Inoue H., Matsumura M., Matsumoto K., Nakano T., Tsuda M., Hamano S., Yoshimura A., Yoshida H., Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice, 10.4049/jimmunol.175.4.2401
  15. Yamanaka A., Hamano S., Miyazaki Y., Ishii K., Takeda A., Mak T. W., Himeno K., Yoshimura A., Yoshida H., Hyperproduction of Proinflammatory Cytokines by WSX-1-Deficient NKT Cells in Concanavalin A-Induced Hepatitis, 10.4049/jimmunol.172.6.3590
  16. Park H., Nat. Immunol., 6, 1133 (2005)
  17. McKenzie B.S., Trends Immunol., 27, 17 (2006)
  18. Langrish C.L., J. Exp. Med., 201, 233 (2005)
  19. Harrington L.E., Nat. Immunol., 6, 1123 (2005)
  20. Infante-Duarte C., Horton H. F., Byrne M. C., Kamradt T., Microbial Lipopeptides Induce the Production of IL-17 in Th Cells, 10.4049/jimmunol.165.11.6107
  21. Aggarwal S., J. Biol. Chem., 278, 1910 (2003)
  22. Cua D.J., Nature, 421, 744 (2003)
  23. Murphy C.A., J. Exp. Med., 198, 1951 (2003)
  24. Veldhoen M., Immunity, 24, 179 (2006)
  25. Bettelli E., Nature, 441, 235 (2006)
  26. Mangan P.R., Nature, 441, 231 (2006)
  27. Villarino A. V., Stumhofer J. S., Saris C. J. M., Kastelein R. A., de Sauvage F. J., Hunter C. A., IL-27 Limits IL-2 Production during Th1 Differentiation, 10.4049/jimmunol.176.1.237
  28. Owaki T., Asakawa M., Kamiya S., Takeda K., Fukai F., Mizuguchi J., Yoshimoto T., IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3, 10.4049/jimmunol.176.5.2773
  29. Bettelli E., J. Exp. Med., 200, 79 (2004)
  30. Pasare C., Science, 299, 1033 (2003)
  31. Kolls J.K., Immunity, 21, 467 (2004)
  32. Sergejeva S., Am. J. Respir. Cell Mol. Biol., 33, 248 (2005)
  33. McQualter J.L., J. Exp. Med., 194, 873 (2001)
  34. Samoilova E.B., J. Immunol., 161, 6480 (1998)
  35. Cho M.-L., Kang J.-W., Moon Y.-M., Nam H.-J., Jhun J.-Y., Heo S.-B., Jin H.-T., Min S.-Y., Ju J.-H., Park K.-S., Cho Y.-G., Yoon C.-H., Park S.-H., Sung Y.-C., Kim H.-Y., STAT3 and NF- B Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice, 10.4049/jimmunol.176.9.5652
  36. Chen Z., Proc. Natl. Acad. Sci. USA, 103, 8137 (2006)
  37. Schimpl A., Cytokine Growth Factor Rev., 13, 369 (2002)
  38. Honda K., Inflamm. Bowel Dis., 11, 1044 (2005)
  39. Jebbari H., Parasite Immunol., 20, 231 (1998)
  40. Suzuki Y., Infect. Immun., 65, 2339 (1997)
  41. Gao W., Int. J. Parasitol., 32, 167 (2002)
  42. Kelly M.N., Infect. Immun., 73, 617 (2005)
  43. Doganci A., Clin. Rev. Allergy Immunol., 28, 257 (2005)
  44. Sedgwick J.D., Proc. Natl. Acad. Sci. USA, 88, 7438 (1991)